Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Global Partners
GLP
$1.68B
| $8.58M | ﹤0.01% |
635,257
-1,202,984
| -65% | -$17.9M |
|
2327
Neurogene
NGNE
$656M
| $8.56M | ﹤0.01% |
48,516
+47,614
| +5,279% | +$9.26M |
|
2328
Benchmark Electronics
BHE
$2.87B
| $8.55M | ﹤0.01% |
370,752
-521
| -0.1% | -$11K |
|
2329
Repligen
RGEN
$7.96B
| $8.53M | ﹤0.01% |
318,222
+173,400
| +120% | +$4.24M |
|
2330
CVR Energy
CVI
$3.58B
| $8.52M | ﹤0.01% |
326,602
-184,925
| -36% | -$5.39M |
|
2331
Acadia Pharmaceuticals
ACAD
$4.43B
| $8.51M | ﹤0.01% |
304,268
+181,489
| +148% | +$3.96M |
|
2332
CALL
Prudential Financial
PRU
$42.4B
| $8.51M | ﹤0.01% |
117,800
+10,100
| +9% | +$704K |
|
2333
PUT
America Movil
AMX
$76.1B
| $8.5M | ﹤0.01% |
547,400
-186,500
| -25% | -$2.58M |
|
2334
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.6B
| $8.47M | ﹤0.01% |
196,122
-65,339
| -25% | -$2.7M |
|
|
DWRE
2335
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
| $8.47M | ﹤0.01% |
216,668
-1,094,875
| -83% | -$42.5M |
|
2336
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
| $8.45M | ﹤0.01% |
67,109
+6,248
| +10% | +$781K |
|
2337
PUT
Texas Instruments
TXN
$252B
| $8.45M | ﹤0.01% |
147,200
-141,700
| -49% | -$7.52M |
|
2338
CALL
Hexcel
HXL
$7.79B
| $8.45M | ﹤0.01% |
193,300
+103,000
| +114% | +$4.33M |
|
2339
PUT
BP
BP
$116B
| $8.44M | ﹤0.01% |
332,541
-53,007
| -14% | -$1.34M |
|
2340
BJ's Restaurants
BJRI
$1.42B
| $8.44M | ﹤0.01% |
203,041
-6,955
| -3% | -$297K |
|
|
ENZY
2341
DELISTED
Enzymotec Ltd
ENZY
| $8.42M | ﹤0.01% |
932,755
-36,272
| -4% | -$316K |
|
2342
Toro Company
TTC
$8.75B
| $8.42M | ﹤0.01% |
195,516
+48,924
| +33% | +$1.88M |
|
2343
PUT
Kinder Morgan
KMI
$71.7B
| $8.39M | ﹤0.01% |
469,528
+65,600
| +16% | +$1.07M |
|
2344
Grupo Aeroportuario del Pacifico
PAC
$12.9B
| $8.36M | ﹤0.01% |
94,258
-8,142
| -8% | -$665K |
|
2345
CALL
MGM Resorts International
MGM
$11.4B
| $8.35M | ﹤0.01% |
389,300
-469,000
| -55% | -$9.27M |
|
2346
POSCO
PKX
$16.1B
| $8.34M | ﹤0.01% |
176,175
+57,972
| +49% | +$2.29M |
|
|
CXP
2347
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $8.31M | ﹤0.01% |
377,747
-213,840
| -36% | -$4.61M |
|
2348
First Trust Materials AlphaDEX Fund
FXZ
$368M
| $8.3M | ﹤0.01% |
269,254
+213,291
| +381% | +$5.87M |
|
|
FTRPR
2349
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
| $8.3M | ﹤0.01% |
+79,500
| New | +$7.43M |
|
|
CACQ
2350
DELISTED
Caesars Acquisition Company
CACQ
| $8.3M | ﹤0.01% |
1,355,997
+21,185
| +2% | +$119K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.